In hi-myc prostate tumors aged to 2 months, Mertk KO mice have increased dead cells, suggesting that Mertk KO tumors have decreased prostate cancer efferocytosis in vivo (Fig. 4G). The gene discussed is MERTK; the disease is prostate carcinoma.